Highlights Voyageur Pharmaceuticals Ltd.

Equities

VM

CA92918C1014

Market Closed - Toronto S.E. Other stock markets 20:58:36 28/06/2024 BST			5-day change	1st Jan Change
0.07 ^CAD	-12.50%		-17.65%	-6.67%

06-11	Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	CI
05-28	Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	06-11	CI
Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	05-28	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	04-26	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	03-26	CI
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	03-13	CI
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	03-04	CI
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance	12-14	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	30/10/23	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	31/07/23	CI
Voyageur Pharmaceuticals Ltd. Announces the Release of the White Paper	12/06/23	CI
Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work At Frances Creek Project Site for Notice of Work & Quarry Permitting	31/05/23	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 28, 2023	28/04/23	CI
Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of Its SmoothX® Contrast Media Confirming Product Superiority	06/04/23	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2022	30/03/23	CI
Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of Smoothx Barium Contrast Media & Financing	08/12/22	CI
Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-Up of SmoothX	28/11/22	CI
Voyageur Pharmaceuticals Ltd. Completes Design of Carbon Neutral Pharmaceutical Facility on Alberta	01/11/22	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	31/10/22	CI
Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems	26/10/22	CI
Voyageur Pharmaceuticals Ltd Signs Memorandum of Understanding with Rain Cage Carbon Inc	24/10/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Voyageur Pharmaceuticals Ltd.

Equities

VM

CA92918C1014

Highlights

Filters